El estudio SELECT, realizado con SEMA 2,4mg, mostr coherentemente una reduccin de eventos cardiovasculares adversos mayores (major adverse cardiac events [MACE]) de triple objetivo compuesto (infarto de miocardio no mortal, accidente cerebrovascular no mortal, mortalidad cardiovascular) del 20% respecto a placebo en una poblacin con enfermedad cardiovascular establecida e IMC superior a 27kg/m2 sin diabetes tras 39,8meses de seguimiento23
Controlled trials in age-related diseases: e.g., osteoarthritis, chronic kidney disease, endocrine decline, frailty syndrome, possibly cardiovascular ageing
Psychiatric considerations in the patient receiving organ transplantation: a clinical case conference
You may need to reduce LPS producing gut bacteria, restore B12 and glutathione and reduce inflammation before supplementing with folate
Among these drugs, Semaglutide and Zepbound are the most famous for weight management